Some Shareholders Feeling Restless Over Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd's (SZSE:301126) P/E Ratio
Mar 14
Have your own idea? Try our Stock Screener
Chinese (SSE) Healthcare Distributors Industry Analysis
UpdatedMar 19, 2025
DataAggregated Company Financials
Companies23
- 7D1.7%
- 3M-6.5%
- 1Y-1.1%
- YTDn/a
The Healthcare Distributors industry is up 3.8% in the last week, with Tibet Rhodiola Pharmaceutical Holding up 11%. The industry has been flat over the past 12 months despite the gain this week. As for the next few years, earnings are expected to grow by 15% per annum.
Industry Valuation and Performance
Has the Chinese Healthcare Distributors Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 19 Mar 2025 | CN¥307.2b | CN¥909.5b | CN¥15.9b | 18.4x | 19.3x | 0.3x |
| Fri, 14 Feb 2025 | CN¥305.0b | CN¥910.6b | CN¥16.5b | 18x | 18.5x | 0.3x |
| Sun, 12 Jan 2025 | CN¥292.2b | CN¥910.6b | CN¥16.5b | 17.3x | 17.8x | 0.3x |
| Tue, 10 Dec 2024 | CN¥333.5b | CN¥910.6b | CN¥16.5b | 19.8x | 20.3x | 0.4x |
| Thu, 07 Nov 2024 | CN¥317.8b | CN¥910.6b | CN¥16.5b | 18.5x | 19.3x | 0.3x |
| Sat, 05 Oct 2024 | CN¥323.8b | CN¥900.2b | CN¥16.4b | 19.4x | 19.8x | 0.4x |
| Mon, 02 Sep 2024 | CN¥271.8b | CN¥900.2b | CN¥16.4b | 16.7x | 16.6x | 0.3x |
| Wed, 31 Jul 2024 | CN¥273.6b | CN¥904.3b | CN¥16.5b | 15x | 16.6x | 0.3x |
| Fri, 28 Jun 2024 | CN¥279.5b | CN¥904.3b | CN¥16.5b | 15.4x | 16.9x | 0.3x |
| Sun, 26 May 2024 | CN¥308.8b | CN¥904.3b | CN¥16.5b | 17.1x | 18.7x | 0.3x |
| Tue, 23 Apr 2024 | CN¥306.6b | CN¥903.8b | CN¥14.9b | 16.2x | 20.5x | 0.3x |
| Thu, 21 Mar 2024 | CN¥312.7b | CN¥894.8b | CN¥15.5b | 14.4x | 20.2x | 0.3x |
| Sat, 17 Feb 2024 | CN¥296.6b | CN¥894.8b | CN¥15.5b | 14.2x | 19.1x | 0.3x |
| Mon, 15 Jan 2024 | CN¥310.5b | CN¥893.5b | CN¥15.5b | 14.5x | 20.1x | 0.3x |
| Wed, 13 Dec 2023 | CN¥330.8b | CN¥893.5b | CN¥15.5b | 15.1x | 21.4x | 0.4x |
| Fri, 10 Nov 2023 | CN¥334.9b | CN¥893.5b | CN¥15.5b | 15.8x | 21.6x | 0.4x |
| Sun, 08 Oct 2023 | CN¥336.3b | CN¥897.9b | CN¥15.9b | 16.3x | 21.1x | 0.4x |
| Tue, 05 Sep 2023 | CN¥326.4b | CN¥897.9b | CN¥15.9b | 16.1x | 20.5x | 0.4x |
| Thu, 03 Aug 2023 | CN¥339.5b | CN¥869.7b | CN¥17.2b | 14.2x | 19.7x | 0.4x |
| Sat, 01 Jul 2023 | CN¥363.3b | CN¥863.1b | CN¥17.1b | 15x | 21.2x | 0.4x |
| Mon, 29 May 2023 | CN¥364.9b | CN¥863.1b | CN¥17.1b | 15.3x | 21.3x | 0.4x |
| Wed, 26 Apr 2023 | CN¥363.2b | CN¥831.0b | CN¥19.2b | 17.5x | 19x | 0.4x |
| Fri, 24 Mar 2023 | CN¥349.3b | CN¥821.5b | CN¥18.7b | 15.4x | 18.7x | 0.4x |
| Sun, 19 Feb 2023 | CN¥346.6b | CN¥821.4b | CN¥18.2b | 15.4x | 19x | 0.4x |
| Tue, 17 Jan 2023 | CN¥341.3b | CN¥821.1b | CN¥18.2b | 16x | 18.7x | 0.4x |
| Thu, 15 Dec 2022 | CN¥342.5b | CN¥821.1b | CN¥18.2b | 18.4x | 18.8x | 0.4x |
| Sat, 12 Nov 2022 | CN¥325.6b | CN¥821.1b | CN¥18.2b | 18.2x | 17.9x | 0.4x |
| Mon, 10 Oct 2022 | CN¥272.0b | CN¥764.7b | CN¥16.8b | 14.7x | 16.2x | 0.4x |
| Wed, 07 Sep 2022 | CN¥289.8b | CN¥764.7b | CN¥16.8b | 18.4x | 17.2x | 0.4x |
| Fri, 05 Aug 2022 | CN¥289.1b | CN¥759.0b | CN¥16.1b | 21.2x | 17.9x | 0.4x |
| Sun, 03 Jul 2022 | CN¥315.3b | CN¥766.9b | CN¥17.6b | 15.7x | 17.9x | 0.4x |
| Tue, 31 May 2022 | CN¥300.4b | CN¥766.9b | CN¥17.6b | 15.6x | 17.1x | 0.4x |
| Thu, 28 Apr 2022 | CN¥276.8b | CN¥761.9b | CN¥18.1b | 12.3x | 15.3x | 0.4x |
| Sat, 26 Mar 2022 | CN¥331.4b | CN¥753.3b | CN¥19.3b | 16.5x | 17.2x | 0.4x |
Price to Earnings Ratio
17.2x
Current Industry PE
- Investors are relatively neutral on the Chinese Healthcare Distributors industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 18.9x.
- The industry is trading close to its 3-year average PS ratio of 0.37x.
Past Earnings Growth
- The earnings for companies in the Healthcare Distributors industry have declined 4.6% per year over the last three years.
- Meanwhile revenues for these companies have grown 6.5% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Comparison
How does Chinese Healthcare Distributors compare with similar industries?
| CN Market | 1.56% | |
| Healthcare | 1.66% | |
| Healthcare Services | 1.70% | |
| Healthcare Distributors | 1.73% | |
| Healthcare Facilities | 2.51% | |
| Healthcare Services | -0.15% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 000503 China Reform Health Management and Services Group | CN¥12.78 | 12.0% +CN¥1.3b | 15.1% | PS34x | |
| 600211 Tibet Rhodiola Pharmaceutical Holding | CN¥39.01 | 9.4% +CN¥1.1b | 9.7% | PE12x | |
| 601607 Shanghai Pharmaceuticals Holding | CN¥19.23 | 0.9% +CN¥667.4m | 10.6% | PE17.7x | |
| 600511 China National Medicines | CN¥31.13 | 2.8% +CN¥641.3m | 4.0% | PE10.8x | |
| 603368 Guangxi LiuYao Group | CN¥18.67 | 5.4% +CN¥382.5m | -12.2% | PE8.3x |
